For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
The closing price of Acurx Pharmaceuticals Inc (NASDAQ: ACXP) was $0.40 for the day, up 9.83% from the previous closing price of $0.36. In other words, the price has increased by $9.83 from its previous closing price. On the day, 0.66 million shares were traded.
Ratios:
Our analysis of ACXP’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 1.19 and its Current Ratio is at 1.19. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jan 06 ’25 when Scodari Joseph C bought 24,631 shares for $1.01 per share. The transaction valued at 25,000 led to the insider holds 27,708 shares of the business.
Sailer Carl bought 24,631 shares of ACXP for $25,000 on Jan 06 ’25. The Director now owns 137,183 shares after completing the transaction at $1.01 per share. On Jan 06 ’25, another insider, LUCI DAVID P, who serves as the President and CEO of the company, bought 49,261 shares for $1.01 each. As a result, the insider paid 50,000 and bolstered with 1,097,458 shares of the company.
Stock Price History:
Over the past 52 weeks, ACXP has reached a high of $3.33, while it has fallen to a 52-week low of $0.30. The 50-Day Moving Average of the stock is -4.94%, while the 200-Day Moving Average is calculated to be -67.64%.
Shares Statistics:
A total of 22.40M shares are outstanding, with a floating share count of 19.45M. Insiders hold about 13.17% of the company’s shares, while institutions hold 6.73% stake in the company.
